Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 FY- Text added to 2018 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
Accoy, adalimumab, adjudicated, Administratiekantoor, Africa, Allen, Almirall, Amphista, antibiotic, antirheumatic, Arlington, bankruptcy, began, Beheer, Beleggingsmaatschappij, Bipartisan, Blueprint, bridging, Bristol, Bulgaria, bulk, bundled, burdensome, BVBA, Cadillac, chapter, Chest, chosen, Ciba, Citigroup, cocllin, column, compartment, Conceptual, constraint, csDMARD, CSR, cybersecurity, cyclophosphamide, Czech, deletion, depository, der, discretionary, dissolution, East, editor, effectenrekeningen, effectuate, EFPIA, embolism, EOW, Evotec, excise, exluding, explicitly, facsimile, Faculty, falsifying, feedback, Fib, fibroblast, Fibrocor, Frank, freedom, FVTOCI, FVTPL, GDPR, GECKO, Geigy, Ghent, graph, Guenter, Gurdon, hardening, Heijde, hemorrhage, hepatic, hesitancy, HHS, Hong, IGUANA, incentivize, incremental, inherited, initated, inlicensed, inseverable, interstitial, Ipsen, ISABELA, ischemia, Kavanaugh, KGaA, Kline, Kong, landscape, Liberty, LO, lodged, LP, lt, MACE, magnetic, Maher, majeure, malignancy, MANTA, Master, Mease, medial, Merck, mid, mRSS, multiregional, myocardial, necessitate, NMSC, Northern, NOVESA, objectionable, occlusion, OGBBA, OIG, Olumiant, Onroerend, outlicensed, Palmer, Parliament, peer, Penulata, perspective, Peter, PINTA, plenary, pneumonia, PoC, pocket, Poland, preclinical, predermined, predetermined, predominance, predominant, presidential, proceeding, proportion, PsA, Pso, Pte, Pty, redundancy, regenerative, reinsurance, reject, reluctance, remarkable, renal, Republic, resonance, retinal, ROCCELLA, Rodnan, RSU, Sand, scleroderma, SCM, Seattle, Sharp, simplified, Singapore, SLE, sprifermin, ssc, staggered, stimulating, subarachnoid, subcutaneously, surrender, surrendering, swiftly, television, Thoracic, thromboembolism, thrombotic, tibiofemoral, Toledo, Ukraine, uncomplicated, understood, uniform, unlisted, unprecedented, untaxed, upadacitinib, usefull, vein, VHI, VHPI, vii, viii, visible, VTE, Wilson, winding
Removed:
acquirer, activated, amortization, antagonist, barely, Bloomberg, bringing, broader, brokerage, Bryan, buyer, buying, call, cap, certificated, CFTR, channel, China, chloride, computation, conductance, conservatively, Cowen, deal, deduct, deducting, defect, doubtful, dropout, EFSF, EFSM, embedded, epithelial, evenly, evidenced, existed, fax, Flatley, folding, formation, FX, Garnier, gating, green, Highland, implying, influencing, insurer, interchangeable, irrecoverable, ivacaftor, JDC, JRC, Kalydeco, Korea, longest, lumacaftor, matched, materialized, membrane, Mine, mutation, negligible, netting, Nomura, ordinarily, Orkambi, outlook, pause, persist, PK, placement, plasma, prevalent, ProQR, realizable, reassessed, recognizing, recommend, refinance, registrar, regulator, rental, restoring, rhythm, robust, SAPHIRA, South, stopped, strike, sweat, theoretical, Timetable, top, transmembrane, transport, uncertificated, underwriter, unencumbered, unobservable, Unresolved, unrestricted, Vertex
Valuein 2017 FY filing- Value in 2018 FY filing
Original filings
Filing view